NSE filing, NSE: SIS. Summary written from the filing by ALFA Finder's alert engine.
SIS Ltd: key numbers
- Share price
- ₹384.35
- Market cap
- ₹5,433 Cr
- Revenue (annual)
- ₹15,982 Cr
- Net profit (annual)
- ₹137.8 Cr
- P/E (TTM)
- 37.1×Sector 43.1×
- Promoter holding
- 71.84%-0.02% QoQ
- FII holding
- 14.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SIS Ltd
All →SIS Board Meeting Date
SIS Ltd intimated that its Board is scheduled for 4 Nov 2026 to consider Q2/H1 FY27 results. Trading window closes 1 Oct–6 Nov 2026.
SIS Management Change
Mr. Vineet Toshniwal has resigned from his position as President (M&A and Investor Relations) at SIS Limited, effective January 31, 2027.
SIS Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026, detailing promoter and public shareholding categories.
SIS Capital Structure Change
SIS Limited closed its share buyback on October 16, 2026, after deploying ₹105.99 Crore to repurchase 25,02,674 equity shares.
- Value
- ₹106.0 Cr
SIS Capital Structure Change
SIS Limited repurchased 10,706 equity shares from the open market at an average price of ₹405.37, totalling approximately ₹0.43 Crore. This report provides daily buyback details.
- Value
- ₹0.43 Cr
SIS Capital Structure Change
SIS Limited repurchased 31,000 equity shares on October 15, 2026, at an average price of ₹407.49 per share as part of its ongoing buyback program.
- Value
- ₹1.26 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.